BioCentury
ARTICLE | Finance

Analyst picks & changes

October 10, 2011 7:00 AM UTC

Immunex Corp.

Several analysts commented last week on Immunex Corp., in anticipation of the upcoming American Society of Clinical Oncology (ASCO) meeting, which will contain data on Pixykine, IMNX's fusion protein of IL-3 and GM-CSF for neutropenia and thrombocytopenia. ...